[HTML][HTML] Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight
Abstract Background Mesenchymal stem cells (MSCs) are a heterogeneous subset of
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight
F Bruna, A Plaza, M Arango, I Espinoza… - Stem Cell Research & …, 2018 - go.gale.com
Background Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
[PDF][PDF] Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight
F Bruna, A Plaza, M Arango, I Espinoza, P Conget - 2018 - academia.edu
Abstract Background: Mesenchymal stem cells (MSCs) are a heterogeneous subset of
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight
F Bruna, A Plaza, M Arango… - Stem cell research …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: A new biosafety insight
FA Bruna, A Plaza, M Arango, I Espinoza… - 2018 - notablesdelaciencia.conicet.gov.ar
Background: Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: A new biosafety insight
FA Bruna, A Plaza, M Arango, I Espinoza… - 2018 - datosdeinvestigacion.conicet.gov.ar
Background: Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: A new biosafety insight
FA Bruna, A Plaza, M Arango, I Espinoza, P Conget - 2018 - ri.conicet.gov.ar
Background: Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight.
F Bruna, A Plaza, M Arango… - Stem Cell Research …, 2018 - search.ebscohost.com
Abstract Background: Mesenchymal stem cells (MSCs) are a heterogeneous subset of
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
[PDF][PDF] Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight
F Bruna, A Plaza, M Arango, I Espinoza, P Conget - 2018 - core.ac.uk
Abstract Background: Mesenchymal stem cells (MSCs) are a heterogeneous subset of
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
stromal cells currently tested for multiple therapeutic purposes. Their potential to home into …
Systemically administered allogeneic mesenchymal stem cells do not aggravate the progression of precancerous lesions: a new biosafety insight
F Bruna, A Plaza, M Arango, I Espinoza, P Conget - 2018 - repositorio.udd.cl
Background: Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal cells
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …
currently tested for multiple therapeutic purposes. Their potential to home into tumors, to …